A study to evaluate the pharmacokinetics and safety of KD4004 after oral administration in healthy adult volunteers
Latest Information Update: 24 Sep 2019
Price :
$35 *
At a glance
- Drugs Dapagliflozin/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Acronyms KD4004_BE
- Sponsors Kyung Dong
- 24 Sep 2019 New trial record